Encompass Health Files 8-K on Financial Results & Operations

Ticker: EHC · Form: 8-K · Filed: Feb 7, 2024 · CIK: 785161

Complexity: simple

Sentiment: neutral

Topics: financial-results, regulation-fd, corporate-update

TL;DR

**Encompass Health just dropped an 8-K about their financial results, get ready for more details soon!**

AI Summary

Encompass Health Corporation filed an 8-K on February 7, 2024, to report its financial results and operations. This filing, under Items 2.02 and 7.01, indicates the company is providing an update on its financial condition, likely ahead of a formal earnings release. For investors, this matters because it offers an early glimpse into the company's performance, which can influence stock price and investment decisions before the full details are publicly available.

Why It Matters

This filing signals that Encompass Health is updating the market on its financial health, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial results and operations, not indicating any immediate new risks.

Analyst Insight

A smart investor would monitor Encompass Health's upcoming announcements for the full financial details hinted at in this 8-K to make informed decisions.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What is the primary purpose of Encompass Health Corporation's 8-K filing on February 7, 2024?

The primary purpose of Encompass Health Corporation's 8-K filing on February 7, 2024, is to report on 'Results of Operations and Financial Condition' under Item 2.02 and 'Regulation FD Disclosure' under Item 7.01, indicating an update on their financial performance.

What is Encompass Health Corporation's state of incorporation and business address?

Encompass Health Corporation is incorporated in Delaware, and its business address is 9001 Liberty Parkway, Birmingham, Alabama 35242.

What is the Commission File Number for Encompass Health Corporation?

The Commission File Number for Encompass Health Corporation is 001-10315, as stated in the filing.

Has Encompass Health Corporation indicated if it is an emerging growth company?

No, Encompass Health Corporation has indicated with a '☐' that it is not an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

What were the former names of Encompass Health Corporation and when did the name changes occur?

Encompass Health Corporation was formerly known as HEALTHSOUTH CORP, with a name change on 19950113, and before that, HEALTHSOUTH REHABILITATION CORP, with a name change on 19920703.

Filing Stats: 2,405 words · 10 min read · ~8 pages · Grade level 15.8 · Accepted 2024-02-07 16:35:14

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

ITEM 2.02. Results of Operations and Financial Condition. On February 7, 2024, Encompass Health Corporation ("Encompass Health" or the "Company") issued a press release reporting the financial results of the Company for the three months and year ended December 31, 2023. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference. The Company uses "same-store" comparisons to explain the changes in certain performance metrics and line items within its financial statements. Same-store comparisons are calculated based on hospitals open throughout both the full current and prior periods presented. These comparisons include the financial results of market consolidation transactions in existing markets, as it is difficult to determine, with precision, the incremental impact of these transactions on the Company's results of operations.

01. Regulation FD Disclosure

ITEM 7.01. Regulation FD Disclosure. See Item 2.02, "Results of Operations and Financial Condition," above. In addition, a copy of the supplemental information which will be discussed during the Company's earnings call at 10:00 a.m. Eastern Time on Thursday, February 8, 2024 is attached to this report as Exhibit 99.2 and incorporated herein by reference. Note Regarding Presentation of Non-GAAP Financial Measures The financial data contained in the press release and supplemental information include non-GAAP financial measures, including the Company's adjusted earnings per share, leverage ratio, Adjusted EBITDA, and adjusted free cash flow. The Company is providing adjusted earnings per share from continuing operations attributable to Encompass Health ("adjusted earnings per share"). The Company believes the presentation of adjusted earnings per share provides useful additional information to investors because it provides better comparability of ongoing operating performance to prior periods given that it excludes the impact of government, class action, and related settlements; professional fees—accounting, tax, and legal; mark-to-market adjustments for stock appreciation rights; gains or losses related to hedging and equity instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims); items related to corporate and facility restructurings; and certain other items the Company believes to be non-indicative of its ongoing operating performance. It is reasonable to expect that one or more of these excluded items will occur in future periods, but the amounts recognized can vary significantly from period to period and may not directly relate to the Company's ongoing operating performance. Accordingly, they can complicate comparisons of the Company's results of operations across periods and comparisons of the Company's results to those of other healthcare compan

Forward-Looking Statements

Forward-Looking Statements The information contained in the press release and supplemental information includes certain estimates, projections, and other forward-looking statements that involve known and unknown risks and relate to, among other things, future events, the business model, strategy, outlook and guidance, growth targets, labor cost trends, financial plans, dividend strategies or payments, effective income tax rates, plans to repurchase its debt or equity securities, future financial performance, projected business results, ability to return value to its shareholders, projected capital expenditures and development plans, leverage ratio, guidance considerations, and the impact of future legislation or regulation. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "targets," "potential," or "continue" or the negative of these terms or other comparable terminology. These estimates, projections, and other forward-looking statements are based on assumptions the Company believes, as of the date hereof, are reasonable. Inevitably, there will be differences between such estimates and actual results, and those differences may be material. There can be no assurance that any estimates, projections, or forward-looking statements will be realized. All such estimates, projections, and forward-looking statements speak only as of the date hereof. The Company undertakes no duty to publicly update or revise that information. You are cautioned not to place undue reliance on the estimates, projections, and other forward-looking statements in this report, the press release, and supplemental information as they are based on current expectations and general assumptions and are subject to various risks, uncertainties, and other factors, including those set forth in the attached press release and in the 2023 Form 10K, when filed, and in other docume

01. Financial Statements and Exhibits

ITEM 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release of Encompass Health Corporation, dated February 7, 2024. 99.2 Supplemental information provided in connection with the fourth quarter 2023 earnings call of Encompass Health Corporation. 104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ENCOMPASS HEALTH CORPORATION By: / S / D OUGLAS E. C OLTHARP Name: Douglas E. Coltharp Title: Executive Vice President and Chief Financial Officer Dated: February 7, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing